Concepedia

Major Pathologic Response

Major Pathologic Response is a histopathological assessment metric in oncology that quantifies the extent of tumor eradication following neoadjuvant immunotherapy by measuring the percentage of residual viable cancer cells in the resected specimen.

391

Publications

62.2K

Citations

4K

Authors

960

Institutions

Publications per year

2017–2026

226

Variants

Mpr

Parents

Publications

391

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

, , +14

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer et al. · Journal of Clinical Oncology · 2012 · 2.7K citations

, , +15

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers

Myriam Chalabi, Lorenzo F. Fanchi, Krijn K. Dijkstra et al. · Nature Medicine · 2020 · 1.4K citations · Full text

, , +14

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

William M. Sikov, Donald A. Berry, Charles M. Perou et al. · Journal of Clinical Oncology · 2014 · 1K citations · Full text

, , +17

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

Heather A. Wakelee, Moïshe Liberman, Terufumi Kato et al. · New England Journal of Medicine · 2023 · 1K citations · Full text

, , +17

1–5 of 391

Authors

4K

  1. II
    Ignacio I. Wistuba

    The University of Texas MD Anderson Cancer Center, United States

    11 publications · 1.3K citations

    11

    h-index

  2. SG
    Stephen G. Swisher

    The University of Texas MD Anderson Cancer Center, United States

    9 publications · 1.1K citations

    9

    h-index

  3. AA
    Ara A. Vaporciyan

    The University of Texas MD Anderson Cancer Center, United States

    8 publications · 1K citations

    8

    h-index

  4. TC
    Tina Cascone

    The University of Texas MD Anderson Cancer Center, United States

    8 publications · 753 citations

    8

    h-index

  5. JA
    Jack A. Roth

    The University of Texas MD Anderson Cancer Center, United States

    6 publications · 707 citations

    6

    h-index

1–5 of 4K

Institutions

960

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    34 h-index

    404 publications

    60K citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    18 h-index

    98 publications

    40.7K citations

  3. Sun Yat-sen University

    Guangzhou, China

    15 h-index

    143 publications

    9.4K citations

  4. Chinese Academy of Medical Sciences & Peking Union Medical College

    Beijing, China

    13 h-index

    135 publications

    37.8K citations

  5. Brigham and Women's Hospital

    Boston, United States

    12 h-index

    18 publications

    1.9K citations

  6. Shanghai Pulmonary Hospital

    Shanghai, China

    12 h-index

    133 publications

    12.3K citations

  7. Cornell University

    Ithaca, United States

    12 h-index

    33 publications

    4.7K citations

  8. The Netherlands Cancer Institute

    Amsterdam, The Netherlands

    12 h-index

    137 publications

    45.2K citations

1–8 of 960

Venues

  1. Journal of Clinical Oncology

    33 publications · 6.7K citations

    23

    h-index

  2. Annals of Surgical Oncology

    26 publications · 1.9K citations

    20

    h-index

  3. Annals of Oncology

    16 publications · 1.9K citations

    15

    h-index

  4. 13

    h-index

  5. Breast Cancer Research and Treatment

    12 publications · 1.1K citations

    11

    h-index

1–5